Replimune Group IncFDA panel backs skin cancer drug trial.
Several stocks made big midday moves following earnings reports and other developments. IES Holdings surged over 30% after beating quarterly expectations and approving a two-for-one stock split, while GoDaddy tumbled 20% on disappointing guidance and a cash flow miss. Newell Brands rose 11% after lifting its full-year earnings outlook above consensus, and SPX Technologies rallied 14% on strong results and raised guidance. Veracyte fell 24% despite beating estimates and raising revenue guidance, and Replimune Group soared over 94% after an FDA panel backed its skin cancer drug trial. Jersey Mike's gained 6% on its second day of trading after a weak debut. Chevron added 1.6% on better-than-expected earnings, while ExxonMobil slipped 2% on a profit miss. Moderna dipped 1% despite a top- and bottom-line beat. Amazon jumped 15% on strong revenue and cloud growth, but Apple dropped more than 9% even with higher iPhone sales. Coinbase slid over 12% after a wider-than-expected loss, Reddit sank 22% on search traffic concerns, and Novo Nordisk fell 9% after a drug trial failed to meet its main goal.
Replimune Group IncFDA panel backs skin cancer drug trial.
Novo Nordisk A/SDrug trial failed to meet main goal, causing 9% drop.
Veracyte IncFell 24% despite beating estimates and raising revenue guidance, likely due to other factors.
Moderna IncTop- and bottom-line beat, though stock dipped.
Apple Inc.Apple dropped more than 9% despite higher iPhone sales, indicating market disappointment with earnings.
Amazon.com IncAmazon jumped 15% on strong revenue and cloud growth.
IES Holdings IncBeats quarterly expectations and approves stock split.
Coinbase Global IncCoinbase slid over 12% after a wider-than-expected loss.
Chevron CorpChevron added 1.6% on better-than-expected earnings.
Godaddy IncGoDaddy tumbled 20% on disappointing guidance and a cash flow miss.
Newell Brands IncLifts full-year earnings outlook above consensus.
Reddit, Inc.Search traffic concerns.
SPX CorpStrong results and raised guidance drove shares up 14%.
Exxon Mobil CorpSlipped 2% on a profit miss.